Historical review from 2026-10-06. Current price and availability are unconfirmed; check the original marketplace.
isMalicious generates $2,076/mo revenue with an exceptional 94.98% profit margin ($1,972/mo net), valued at only 1.48x annual profit—well below market for any software business. Platform verification confirms the financials. At 19 months old with a focused cybersecurity intelligence niche and established API/integration suite (STIX/TAXII, OpenCTI, MCP), this represents rare combination of strong unit economics, low valuation multiple, and operational maturity. Buyer should confirm customer acquisition sources, churn, and roadmap dependencies to complete the due diligence picture.
Acquiring isMalicious captures 19 months of operational track record, verified $1,972/mo cash profit, and a fully integrated threat intelligence API suite (STIX/TAXII, OpenCTI, MCP) already serving paying customers in a specialized cybersecurity niche. Rebuilding the software alone (REST API, threat data pipelines, and integrations) would cost $8K–$16K in managed infrastructure and AI-assisted development over 12 weeks, but the real value is the established revenue stream, customer relationships, and domain credibility in enterprise security—assets that cannot be replicated quickly. At 1.48x profit multiple with 95% margins, the purchase captures durable business traction at a valuation below replacement software cost, making acquisition the lower-risk path to revenue.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
isMalicious is a suite of tools of cyberthreats intelligence, SIEM threatl intelligence API, STIX / TAXII, OpenCTI, MCP server.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.